genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
GEN Edge
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
GEN Edge
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
GEN Edge
A ‘Human’ Touch vs. COVID-19
GEN Edge
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
News
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Artificial Intelligence
How AI Scratches More Than Just the Surface in Neurodegeneration
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Insights
All
Trends for 2020
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
Bioprocessing
Data Management in the DNA of New Gene Therapy Plant
Bioprocessing
Personalized Medicine Manufacturing Needs “Debugging Tools”
A-Lists
Top 50 NIH-Funded Institutions of 2020
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
GEN Edge
GEN Edge
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
GEN Edge
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
GEN Edge
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
GEN Edge
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
GEN Edge
A ‘Human’ Touch vs. COVID-19
GEN Edge
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
GEN Edge
FDA Approves Guardant Test as First Pan-Cancer Liquid Biopsy, CDx for...
GEN Edge
A Unicorn Rivalry Shaping the Future of the Synbio Industry
GEN Edge
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
GEN Edge
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
GEN Edge
Rough Surf Ahead for California
GEN Edge
Alpine’s Gold Standard Approach to Drug Development
GEN Edge
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with...
GEN Edge
Obsidian’s SWFT Response to COVID-19
GEN Edge
AbCellera’s CEO: Flattening the Curve of Technology Development
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Drug resistant E. coli could be rapidly detected using newly developed technique. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/24661308922_3eb66388f6_o8020087571-218x150.jpg "Dangerous E. coli Strain Reveals Potential New Drug Target")
